Yurttaş, VeyselŞereflican, MuratErkoçoğlu, MustafaTerzi, Elçin HakanKükner, AyselOral, Mesut2021-06-232021-06-2320151011-1344https://doi.org/10.1016/j.jphotobiol.2015.06.011https://hdl.handle.net/20.500.12491/8268Allergic rhinitis is one of the most common health problems and has a major effect on quality of life. Although new-generation antihistamines and nasal steroids are the main treatment options, complete resolution cannot be obtained in some patients. Besides common side effects such as nasal irritation and epistaxis, the use of these drugs is controversial in some patients, such as pregnant or breastfeeding women. These findings highlight the need for new treatment options. Although phototherapy has been successfully used in the treatment of atopic dermatitis, which is an IgE-mediated disease and shares several common pathogenic features with allergic rhinitis, there are limited studies about its role in the treatment of allergic rhinitis. In this study, we aimed to evaluate and compare the histopathological effects of intranasal phototherapy (Rhinolight) and nasal corticosteroid treatment on the nasal mucosa in allergic rhinitis in a rabbit model and we found that both treatment options significantly reduced inflammation in the nasal mucosa without increasing apoptosis of mucosal cells. (C) 2015 Elsevier B.V. All rights reserved.eninfo:eu-repo/semantics/closedAccessAllergic InflammationAllergic RhinitisHistopathological FindingsIntranasal PhototherapyIntranasal Steroid TreatmentRhinolightArticle10.1016/j.jphotobiol.2015.06.011149289291261231902-s2.0-84933041913Q1WOS:000358628400035Q2